Koyfin Home > Directory > Health Care > Arena Pharmaceutical > Cash from Financing Activities

Arena Pharmaceutical Cash from Financing Activities Chart (ARNA)

Arena Pharmaceutical annual/quarterly Cash from Financing Activities from 2000 to 2018.
  • Arena Pharmaceutical Cash from Financing Activities for the quarter ending September 09, 2018 was $0m a -39,979.47% decrease of -166m year over year
  • Arena Pharmaceutical Cash from Financing Activities for the last 12 months ending September 09, 2018 was $385m a 36.29% increase of 140m year over year
  • Arena Pharmaceutical Annual Cash from Financing Activities for 2017 was $245m a 100.93% increase of 248m from 2016
  • Arena Pharmaceutical Annual Cash from Financing Activities for 2016 was $-2m a 4,518.35% decrease of -103m from 2015
  • Arena Pharmaceutical Annual Cash from Financing Activities for 2015 was $101m a 96.87% increase of 98m from 2014
Other Cash Flow Metrics:
  • Arena Pharmaceutical Cash Flow from Operations for the quarter ending September 09, 2018 was $-31m a 40.98% decrease of -13m year over year
  • Arena Pharmaceutical Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-18m a 99.28% decrease of -18m year over year
  • Arena Pharmaceutical Total Revenue for the quarter ending September 09, 2018 was $4m a -330.00% decrease of -12m year over year
View Chart On Koyfin

Quarterly ARNA Cash from Financing Activities Data

09/2018$0m
06/2018$1m
03/2018$384m
09/2017$166m
06/2017$75m
03/2017$4m
09/2016$-1m
06/2016$-1m
03/2016$-1m
12/2015$0m

Annual ARNA Cash from Financing Activities Data

2017$245m
2016$-2m
2015$101m
2014$3m
2013$2m
2012$144m
2011$-14m
2010$90m
2009$167m
2008$-53m